Answers are grounded in this paper and cite their sources.
Every third patient who makes an appointment with a specialist (dermatologist or allergologist-immunologist) suffers from itchy dermatosis. Traditionally, in Russia this term includes such diseases as atopic dermatitis, contact dermatitis, eczema and urticaria. Pathogenesis of these diseases is based on immune-mediated skin inflammation characterized by itching of varying degrees of intensity. Itching can affect productivity, sleep quality and mood, aggravate skin diseases and lead to complications. Modern antihistamines are used to control itching as monotherapy or as an addition to topical treatment. Among non-sedating antihistamines, levocetirizine holds a special place with its favorable pharmacological profile. Rapid action and optimal duration of action in combination with low risk of drug interactions, good tolerability, absence of influence on cognitive and psychomotor functions and cardiac safety make levocetirizine the drug of first choice in treatment of skin itching in itchy dermatoses. Real practice confirms the claimed characteristics of the medicine.
No takes yet. Share an insight, caveat, or question.
Nenasheva et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: